Lexicon Pharmaceuticals
LXRX
#7256
Rank
A$0.71 B
Marketcap
A$1.98
Share price
0.00%
Change (1 day)
42.00%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.28. In 2024 the company made an earnings per share (EPS) of A-$0.96 an increase over its 2023 EPS that were of A-$1.20.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-68.52%
2024A-$0.96-20%
2023A-$1.2031.15%
2022A-$0.91-0%
2021A-$0.9110.91%
2020A-$0.82-145.08%
2019A$1.83-206.09%
2018A-$1.72-5.74%
2017A-$1.83-10.95%
2016A-$2.052640%
2015A-$0.07498-96.34%
2014A-$2.05-2.53%
2013A-$2.10-9.09%
2012A-$2.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
A-$115.04 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$65.15-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.91 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.08-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$26.00-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.81 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$6.70-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.58-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.12 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA